Thailand's Prime Minister Aims to Roll Back Cannabis Legalization Amid Rising Concerns
Citing concerns with the increasing prevalence of cannabis in the country, the Prime Minister plans to curb ongoing legalization.
In a recent television interview, Thailand’s newly elected Prime Minister, Srettha Thavisin, stated that sales and consumption of cannabis for recreational purposes is too extensive and declared an effort to halt ongoing legalization in the country (1). Within the next six months, the government will reportedly limit use to medical purposes only, though details of the exact plans remain unclear (2,3).
In 2018, Thailand became the first country in Asia to allow cannabis for medical use, and in 2022 the country legalized cannabis for recreational use and removed it from the list of narcotics (2). Currently, anyone over the age of 20 who is not pregnant or breastfeeding is legally allowed to use cannabis or consume its extracts in food in private residences or in licensed restaurants (3). Home cultivation is also permitted, but only after informing the Thai government first (2). Despite these permissions, Thailand does not have regulations controlling the growing and selling of cannabis (2).
“The law will need to be rewritten,” Srettha stated (3). “It needs to be rectified. We can have that regulated for medical use only.” He also explained that an agreement had been formed among the 11 political parties to sanctify this push as government policy, citing widespread drug activity (2).
Since decriminalization, the country has nearly 6,000 cannabis stores, and according to a study published by "Bangkok Times" in 2022 from the University of the Thai Chamber of Commerce, the country’s cannabis market is expected to generate $1.68 billion in 2025 (2). The country has also seen the rise of cannabis-themed massages, cruises, and farm tours (4).
For a look into modern and traditional uses of psychedelics in Thailand, watch our onsite interview with Dr. Aimon Kopera at the Cannabis Science Conference Fall 2023.
References
- MJBizDaily Staff. Thailand plans cannabis law rewrite to allow only medical sales https://mjbizdaily.com/thailand-plans-cannabis-law-rewrite-to-allow-only-medical-sales/?utm_medium=email&utm_source=newsletter&utm_campaign=MJD_20230922_NEWS_Daily (accessed Oct 6, 2023).
- Sabaghi, D. Thailand to reconsider cannabis decriminalization amid thriving market https://www.forbes.com/sites/dariosabaghi/2023/10/02/thailand-to-reconsider-cannabis-decriminalization-amid-thriving-market/?sh=f47188046907 (accessed Oct 6, 2023).
- Lopez, R. Thailand to clamp down on cannabis use in major U-turn on Drug Policy https://www.theguardian.com/world/2023/sep/22/thailand-to-clamp-down-on-cannabis-use-in-major-u-turn-on-drug-policy (accessed Oct 6, 2023).
- Compton, N. Behind the scenes in Thailand’s booming weed business https://www.washingtonpost.com/travel/2023/06/08/thailand-legal-weed-shops-tourists/ (accessed Oct 6, 2023).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
